Traduire
Le projet EMBOBIO reçoit le prix de l’innovation AP-HM 2022
NEOSTEM : soigner l’encéphalopathie anoxo-ischémique du nouveau-né grâce à la thérapie cellulaire
Spreading safe, cheap embolization around the world
Le CERIMED, une plate-forme d’imagerie transversale, interdisciplinaire et fédératrice
R&D
Located on the Marseille-Timone Campus, CERIMED is an innovative multidisciplinary working environment opened to academics and SME for the development and validation of novel medical imaging techniques and protocols.
Services
CERIMED offers its equipments and knowledge in the form of a range of service offers for academics and industries. Each CERIMED department may contribute to development and validation of your innovative medical imaging techniques and protocols.
Training
Implement a transversal way of learning and training, meeting the various concerned disciplines (physics, biology, medicine, radiopharmacy, ...) and the industry, but also offer a theoretical and practical training to the medical imaging techniques.
Recent Posts
-
Symposium’23 Program
“Innovative drugs & health products,
imaging & theranostics agents –
cell & gene biotherapies”, March 17, 2023, 13:30 - 3e matinée Carnot Star “9-12 Recherche-Industrie” dédiée à l’Imagerie, 17 Mars 2023, 8h30
- FairEmbo en Afrique : “Ce médecin marseillais sauve des femmes avec des bouts de ficelle”
- Webinar: Discover Radiotheranostics in Nuclear Medicine (15 Sept. 2022)
- Le projet EmboBio, développé au CERIMED, a reçu le prix de l’innovation AP-HM 2022
Dernières Publications (5/471)
- Long-Depaquit, T, Sordelli, F, Charvet, AL, Agüero, C, Secco, S, Sarrazin, C et al.. Bladder drainage using the coreflow prostatic stent after REZUM therapy. World J Urol. 2026;44 (1):. doi: 10.1007/s00345-026-06569-w. PubMed PMID:42347888 .
- Grüter, BE, Vingadassalom, S, Hägler, J, Gruber, P, Berberat, J, Agripnidis, T et al.. Arterial spin labeling (ASL) MRI for detection and prognostication of residual perfusion in adult brain AVMs after gamma knife radiosurgery: A multicenter study. J Neuroradiol. 2026;53 (5):101580. doi: 10.1016/j.neurad.2026.101580. PubMed PMID:42341694 .
- Terroir, M, Lusque, A, Hindié, E, Taieb, D, Eberle-Pouzeratte, MC, Verbeke, S et al.. Prospective study on the [18F]FDOPA PET/CT role in the management of medullary thyroid cancer patients with high residual calcitonin level after surgery. Eur J Nucl Med Mol Imaging. 2026; :. doi: 10.1007/s00259-026-07992-2. PubMed PMID:42337037 .
- Fusella Giuntini, M, Voyant, C, Taieb, D, Barbolosi, D. A computational framework for optimizing radioiodine therapy protocols in metastatic thyroid cancer. Sci Rep. 2026; :. doi: 10.1038/s41598-026-56267-1. PubMed PMID:42289454 .
- Park, S, Pin-Barre, C, Luzel, B, Cousinie, S, Garrigue, P, Pellegrino, C et al.. Injectable and degradable hydrogel: in vitro drug release behavior and evaluation in a brain repair context. Int J Pharm. 2026;700 :127030. doi: 10.1016/j.ijpharm.2026.127030. PubMed PMID:42208824 .